Lilly’s GLP-1 Scale Offsets Lower Prices, but Its Premium Demands More
Lilly’s volumes and gross margins rose despite lower prices. One-off revenue benefits, acquisition charges and a 36.3x guidance multiple complicate the investment case.
Read full briefing



